Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/12074
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Panagiotopoulos, Sianna | en |
dc.contributor.author | Nayler, W G | en |
dc.date.accessioned | 2015-05-16T01:43:13Z | - |
dc.date.available | 2015-05-16T01:43:13Z | - |
dc.date.issued | 1987-12-01 | en |
dc.identifier.citation | Journal of Cardiovascular Pharmacology; 10(6): 683-91 | en |
dc.identifier.govdoc | 2450239 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/12074 | en |
dc.description.abstract | The excessive gain in Ca2+ that occurs when hearts are reperfused after prolonged periods of ischemia contributes to cell death and tissue necrosis. The following experiments were undertaken to determine whether nicotine, in a concentration equivalent to the peak concentration present in plasma after cigarette smoke inhalation, alters reperfusion-induced Ca2+ gain in isolated rat hearts. Nicotine (0.15 microgram/ml) failed to increase tissue Ca2+ during aerobic perfusion but increased Ca2+ gain during reperfusion after 30 (p less than 0.02) or 60 (p less than 0.02) min of normothermic ischemia. The increase of Ca2+ gain was independent of a nicotine-induced release of norepinephrine (NE) or an altered "reflow area", heart rate, force of contraction, or end-diastolic resting tension. Pretreatment for 3 days with anipamil (20 mg/kg), a long-acting calcium channel blocker, attenuated the reperfusion-induced Ca2+ gain after 30 min of global ischemia, and reduced (p less than 0.001) the nicotine-induced exacerbation of that gain, without altering tissue ATP or creatine phosphate (CP). Verapamil (1 X 10(-6) M) reduced (p less than 0.02) the nicotine-induced exacerbation of Ca2+ gain caused by reperfusion after 30 min of ischemia. | en |
dc.language.iso | en | en |
dc.subject.other | Adenosine Triphosphate.analysis | en |
dc.subject.other | Animals | en |
dc.subject.other | Calcium.metabolism | en |
dc.subject.other | Calcium Channel Blockers.pharmacology | en |
dc.subject.other | Coronary Circulation.drug effects | en |
dc.subject.other | Coronary Disease.metabolism.physiopathology | en |
dc.subject.other | Female | en |
dc.subject.other | Heart Rate.drug effects | en |
dc.subject.other | In Vitro Techniques | en |
dc.subject.other | Nicotine.toxicity | en |
dc.subject.other | Norepinephrine.metabolism | en |
dc.subject.other | Perfusion | en |
dc.subject.other | Phosphocreatine.analysis | en |
dc.subject.other | Propylamines.pharmacology | en |
dc.subject.other | Rats | en |
dc.subject.other | Rats, Inbred Strains | en |
dc.title | Nicotine-induced calcium overload during postischemic reperfusion. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Journal of Cardiovascular Pharmacology | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia | en |
dc.description.pages | 683-91 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/2450239 | en |
dc.identifier.orcid | 0000-0002-0845-0001 | - |
dc.type.austin | Journal Article | en |
local.name.researcher | Panagiotopoulos, Sianna | |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Office for Research | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.